Elevance Health downgraded by BofA Securities with a new price target
$ELV
Medical Specialities
Health Care
BofA Securities downgraded Elevance Health from Buy to Neutral and set a new price target of $530.00 from $646.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/15/2025 | $529.00 | Outperform → Neutral | Robert W. Baird |
| 3/17/2025 | $450.00 | Hold → Buy | Argus |
| 1/22/2025 | $520.00 → $440.00 | Overweight → Equal-Weight | Stephens |
| 10/18/2024 | Buy → Hold | Argus | |
| 7/18/2024 | $646.00 → $530.00 | Buy → Neutral | BofA Securities |
| 6/24/2024 | $643.00 | Overweight | Morgan Stanley |
| 5/30/2024 | $649.00 | Outperform | Robert W. Baird |
| 3/6/2024 | $584.00 | Overweight | Barclays |